Show simple item record

dc.contributor.authorSalazar-Vizcaya, L
dc.contributor.authorKeiser, O
dc.contributor.authorKarl, T
dc.contributor.authorDavies, MA
dc.contributor.authorHaas, Andreas D
dc.contributor.authorBlaser, N
dc.contributor.authorCox, V
dc.contributor.authorEley, B
dc.contributor.authorRabie, H
dc.contributor.authorMoultrie, H
dc.contributor.authorGiddy, J
dc.contributor.authorWood, R
dc.contributor.authorEgger, M
dc.contributor.authorEstill, J
dc.date.accessioned2017-03-31T18:28:38Z
dc.date.available2017-03-31T18:28:38Z
dc.date.issued2014-10-23
dc.date.submitted2017-03-30
dc.identifier.citationViral Load Versus CD4⁺ Monitoring and 5-Year Outcomes of Antiretroviral Therapy in HIV-Positive Children in Southern Africa: a Cohort-Based Modelling Study. 2014, 28 (16):2451-60 AIDSen
dc.identifier.issn1473-5571
dc.identifier.pmid25392857
dc.identifier.urihttp://hdl.handle.net/10144/618880
dc.description.abstractMany paediatric antiretroviral therapy (ART) programmes in Southern Africa rely on CD4⁺ to monitor ART. We assessed the benefit of replacing CD4⁺ by viral load monitoring.
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subjectviral loaden
dc.subject.meshAdolescenten
dc.subject.meshAfrica, Southernen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshCD4-Positive T-Lymphocytesen
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshCohort Studiesen
dc.subject.meshDrug Monitoringen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshInfanten
dc.subject.meshMaleen
dc.subject.meshModels, Theoreticalen
dc.subject.meshSurvival Analysisen
dc.subject.meshTreatment Outcomeen
dc.subject.meshViral Loaden
dc.titleViral Load Versus CD4⁺ Monitoring and 5-Year Outcomes of Antiretroviral Therapy in HIV-Positive Children in Southern Africa: a Cohort-Based Modelling Studyen
dc.identifier.journalAIDS (London, England)en
refterms.dateFOA2019-03-04T13:16:03Z
html.description.abstractMany paediatric antiretroviral therapy (ART) programmes in Southern Africa rely on CD4⁺ to monitor ART. We assessed the benefit of replacing CD4⁺ by viral load monitoring.


Files in this item

Thumbnail
Name:
Salazar-Vizcaya L et al - 2014 ...
Size:
442.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record